Cargando…

Key Genes and Prognostic Analysis in HER2+ Breast Cancer

Human epidermal growth factor 2 (HER2)+ breast cancer is considered the most dangerous type of breast cancers. Herein, we used bioinformatics methods to identify potential key genes in HER2+ breast cancer to enable its diagnosis, treatment, and prognosis prediction. Datasets of HER2+ breast cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Yujie, Liang, Wei, Ji, Yucheng, Li, Zhongxian, Jia, Rong, Liang, Ying, Ning, Pengfei, Xu, Yingqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844453/ https://www.ncbi.nlm.nih.gov/pubmed/33499770 http://dx.doi.org/10.1177/1533033820983298

Ejemplares similares

Prognosis related genes in HER2+ breast cancer based on weighted gene co-expression network analysis
por: Weng, Yujie, et al.
Publicado: (2023)

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
por: Jia, Rong, et al.
Publicado: (2020)

A novel approach to analyze the association characteristics between post-spliced introns and their corresponding mRNA
por: Bo, Suling, et al.
Publicado: (2023)

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits
por: Weng, Yujie, et al.
Publicado: (2023)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

Prognostic Significance of HER2 Gene Amplification According to Stage of Breast Cancer
por: Kim, Yong-Seok, et al.
Publicado: (2008)

Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis
por: Tong, Zhen-Jun, et al.
Publicado: (2017)

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
por: Zhou, Danyang, et al.
Publicado: (2023)

Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods
por: Yang, Ziguo, et al.
Publicado: (2023)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
por: Pizzuti, Laura, et al.
Publicado: (2021)

Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review
por: Wang, Chaokun, et al.
Publicado: (2020)

Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment
por: Ye, Qian, et al.
Publicado: (2020)

A Prognosis Classifier for Breast Cancer Based on Conserved Gene Regulation between Mammary Gland Development and Tumorigenesis: A Multiscale Statistical Model
por: Tian, Yingpu, et al.
Publicado: (2013)

Combining conventional ultrasound and ultrasound elastography to predict HER2 status in patients with breast cancer
por: Zhuo, Xiaoying, et al.
Publicado: (2023)

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab
por: Ran, Ran, et al.
Publicado: (2020)

Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis
por: You, Zicong, et al.
Publicado: (2021)

Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
por: Chen, De-Lun, et al.
Publicado: (2022)

Prognostic significance of Ki67 in Chinese women diagnosed with ER(+)/HER2(−) breast cancers by the 2015 St. Gallen consensus classification
por: Hu, Yue, et al.
Publicado: (2017)

Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease
por: Lu, Yujie, et al.
Publicado: (2023)

Prognostic significance of HER3 in patients with malignant solid tumors
por: Li, Qin, et al.
Publicado: (2017)

Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer’s Disease
por: Liang, Jia-Wei, et al.
Publicado: (2018)

Incidence and prognostic impact of HER2‐positivity loss after dual HER2‐directed neoadjuvant therapy for HER2+ breast cancer
por: LeVee, Alexis, et al.
Publicado: (2023)

HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis
por: Xu, Qian-Qian, et al.
Publicado: (2016)

Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer
por: Liu, Qian, et al.
Publicado: (2023)

Effects of HER2 status on the prognosis of male breast cancer: a population-based study
por: Chen, Liang, et al.
Publicado: (2019)

Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases
por: Zhu, Siji, et al.
Publicado: (2023)

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
por: Rui, Tao, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer
por: Zhang, Di, et al.
Publicado: (2022)

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
por: Masarwah, Amro, et al.
Publicado: (2016)

High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer
por: Liu, Yu-Lin, et al.
Publicado: (2015)

The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
por: Machleidt, Anna, et al.
Publicado: (2013)

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
por: Ying Zhi, Lu, et al.
Publicado: (2018)

LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer
por: Yu, Shao-Hua, et al.
Publicado: (2021)

Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma
por: Song, Ying-Jian, et al.
Publicado: (2018)

Bioinformatics analysis revealing prognostic significance of RRM2 gene in breast cancer
por: Chen, Wei-xian, et al.
Publicado: (2019)

Prognostic significance of the expression of HER family members in primary osteosarcoma
por: Wang, Sheng-Lin, et al.
Publicado: (2018)

The Clinical Efficacy and Cardiotoxicity of Fixed-Dose Monthly Trastuzumab in HER2-Positive Breast Cancer: A Single Institutional Analysis
por: Wu, Yi-Ying, et al.
Publicado: (2016)

Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
por: Löb, Sanja, et al.
Publicado: (2022)

A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer
por: Liu, Dan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ape34r7q7oh7n5ob82oh1u7e1d